4//SEC Filing
UVEGES GEORGE 4
Accession 0001209191-17-052216
CIK 0001123494other
Filed
Sep 10, 8:00 PM ET
Accepted
Sep 11, 4:04 PM ET
Size
23.3 KB
Accession
0001209191-17-052216
Insider Transaction Report
Form 4
UVEGES GEORGE
Director
Transactions
- Exercise/Conversion
Common Stock
2017-09-07$2.28/sh+23,720$54,082→ 188,440 total - Exercise/Conversion
Common Stock
2017-09-07$2.59/sh+22,545$58,392→ 194,345 total - Tax Payment
Common Stock
2017-09-07$3.25/sh−17,967$58,393→ 176,378 total - Exercise/Conversion
Common Stock
2017-09-07$2.56/sh+21,213$54,305→ 197,591 total - Tax Payment
Common Stock
2017-09-07$3.25/sh−16,640$54,080→ 171,800 total - Tax Payment
Common Stock
2017-09-07$3.25/sh−16,709$54,304→ 180,882 total - Exercise/Conversion
Stock option (right to buy)
2017-09-07−22,545→ 0 totalExercise: $2.59From: 2014-06-04Exp: 2020-06-04→ Common Stock, par value $0.01 per share (22,545 underlying) - Exercise/Conversion
Stock option (right to buy)
2017-09-07−23,720→ 0 totalExercise: $2.28From: 2013-05-21Exp: 2019-05-21→ Common Stock, par value $0.01 per share (23,720 underlying) - Exercise/Conversion
Stock option (right to buy)
2017-09-07−21,213→ 0 totalExercise: $2.56From: 2016-06-01Exp: 2022-06-01→ Common Stock, par value $0.01 per share (21,213 underlying)
Footnotes (8)
- [F1]Includes (a) a deferred stock award of 31,300 restricted stock units which fully vest on the earlier of (i) the date of the Issuer's next Annual Meeting of Stockholders after May 18, 2017, immediately prior to the commencement of such meeting, and (ii) May 18, 2018; (b) a deferred stock award of 11,150 restricted stock units which vest quarterly in equal installments on September 30, 2017 and December 31, 2017; and (c) 145,990 shares of common stock held by the Reporting Person.
- [F2]Represents the number of shares of common stock that the Reporting Person attested to the ownership thereof in accordance with the Issuer's Third Amended and Restated 2000 Stock Option and Incentive Plan, as amended, in connection with the payment of the option exercise price. With respect to each option exercise, the Issuer only delivered the net amount of the option shares (after reducing the option shares by the amount of shares subject to such attestation) to the Reporting Person and such attestation shares were not sold by the Reporting Person or delivered to the Issuer. Nevertheless, the SEC deems such exercise and related attestation to be a disposition of shares for purposes of Section 16(a) of the Securities Exchange Act of 1934.
- [F3]Includes (a) a deferred stock award of 31,300 restricted stock units which fully vest on the earlier of (i) the date of the Issuer's next Annual Meeting of Stockholders after May 18, 2017, immediately prior to the commencement of such meeting, and (ii) May 18, 2018; (b) a deferred stock award of 11,150 restricted stock units which vest quarterly in equal installments on September 30, 2017 and December 31, 2017; and (c) 129,350 shares of common stock held by the Reporting Person.
- [F4]Includes (a) a deferred stock award of 31,300 restricted stock units which fully vest on the earlier of (i) the date of the Issuer's next Annual Meeting of Stockholders after May 18, 2017, immediately prior to the commencement of such meeting, and (ii) May 18, 2018; (b) a deferred stock award of 11,150 restricted stock units which vest quarterly in equal installments on September 30, 2017 and December 31, 2017; and (c) 151,895 shares of common stock held by the Reporting Person.
- [F5]Includes (a) a deferred stock award of 31,300 restricted stock units which fully vest on the earlier of (i) the date of the Issuer's next Annual Meeting of Stockholders after May 18, 2017, immediately prior to the commencement of such meeting, and (ii) May 18, 2018; (b) a deferred stock award of 11,150 restricted stock units which vest quarterly in equal installments on September 30, 2017 and December 31, 2017; and (c) 133,928 shares of common stock held by the Reporting Person.
- [F6]Includes (a) a deferred stock award of 31,300 restricted stock units which fully vest on the earlier of (i) the date of the Issuer's next Annual Meeting of Stockholders after May 18, 2017, immediately prior to the commencement of such meeting, and (ii) May 18, 2018; (b) a deferred stock award of 11,150 restricted stock units which vest quarterly in equal installments on September 30, 2017 and December 31, 2017; and (c) 155,141 shares of common stock held by the Reporting Person.
- [F7]Includes (a) a deferred stock award of 31,300 restricted stock units which fully vest on the earlier of (i) the date of the Issuer's next Annual Meeting of Stockholders after May 18, 2017, immediately prior to the commencement of such meeting, and (ii) May 18, 2018; (b) a deferred stock award of 11,150 restricted stock units which vest quarterly in equal installments on September 30, 2017 and December 31, 2017; and (c) 138,432 shares of common stock held by the Reporting Person.
- [F8]Represent the exercise of stock options granted pursuant to the Issuer's 2000 Stock Option and Incentive Plan, as amended.
Documents
Issuer
HARVARD BIOSCIENCE INC
CIK 0001123494
Entity typeother
Related Parties
1- filerCIK 0001124927
Filing Metadata
- Form type
- 4
- Filed
- Sep 10, 8:00 PM ET
- Accepted
- Sep 11, 4:04 PM ET
- Size
- 23.3 KB